# Exploring MOTS-c: Insights from Mitochondrial-Derived Microproteins in Disease Mechanisms

Canonical source: https://retacompare.com/research/exploring-mots-c-insights-from-mitochondrial-derived-microproteins-in-disease-mechanisms

Mitochondrial & Longevity · 2026-02-01


    MOTS-c is a mitochondrial-derived microprotein that plays a crucial role in cellular decision-making related to metabolism and disease. Recent research highlights its significance in regulating apoptosis, nutrient sensing, and redox balance, particularly in the context of cancer and neurodegeneration. Understanding the mechanisms of MOTS-c can provide new avenues for therapeutic interventions in these complex diseases.

 What this study examined

This study focuses on mitochondrial-derived microproteins (MDPs), including MOTS-c, and their roles in various diseases such as cancer and neurodegeneration. The authors synthesized findings from recent advances in mitoribosome profiling and proteogenomics to elucidate the mechanisms by which MDPs influence cellular processes. The review encompasses a range of experimental models and highlights the diverse signaling pathways activated by different MDPs.

 Why it matters for MOTS-c research

The exploration of MOTS-c is particularly relevant given its involvement in critical cellular functions that can influence disease outcomes. The study's findings suggest that MOTS-c operates through the AMPK/NRF2-LARS1/mTORC1 pathway, which is essential for maintaining cellular homeostasis and responding to metabolic stress. This positions MOTS-c as a potential target for therapeutic strategies aimed at modulating these pathways in diseases characterized by mitochondrial dysfunction.

 Key findings

MOTS-c is part of a group of mitochondrial-derived microproteins that impact apoptosis and nutrient sensing.

MDPs, including MOTS-c, can influence redox balance and mito-nuclear communication.

The review discusses the inverse comorbidity between cancer and Alzheimer's disease, highlighting the dual role of MDPs.

Distinct signaling pathways are activated by various MDPs, suggesting tailored therapeutic approaches.

Recent technological advances have accelerated the discovery of MDPs and their functional characterization.

MDPs represent a druggable signaling layer with context-dependent effects across diseases.

 How MOTS-c works (background)

MOTS-c is a peptide encoded by mitochondrial DNA that plays a significant role in cellular metabolism and stress responses. It has been shown to activate the AMPK pathway, which is crucial for energy homeostasis, particularly under conditions of metabolic stress. By influencing the NRF2 pathway, MOTS-c also helps regulate oxidative stress responses, thereby providing neuroprotection in post-mitotic tissues. The interplay between MOTS-c and other signaling molecules, such as LARS1 and mTORC1, further underscores its importance in metabolic regulation and cellular survival.

 Practical takeaways for researchers

Researchers investigating MOTS-c should consider its multifaceted roles in cellular signaling and disease processes. The distinct pathways activated by MOTS-c suggest that targeted interventions could yield significant therapeutic benefits in conditions like cancer and neurodegenerative diseases. Additionally, the ongoing advancements in proteogenomics and mitochondrial profiling techniques may facilitate deeper insights into the functional roles of MOTS-c and related microproteins. For those interested in peptide research, exploring the potential of MOTS-c in therapeutic applications could be a promising avenue.

 FAQ

 What role does MOTS-c play in cellular metabolism?

MOTS-c is involved in regulating key metabolic pathways, particularly through the activation of AMPK, which helps maintain energy balance in cells.

 How does MOTS-c relate to cancer and neurodegeneration?

MOTS-c has been implicated in the mechanisms underlying both cancer survival and neuroprotection, suggesting a complex relationship between these diseases.

 Are there therapeutic applications for MOTS-c?

Yes, MOTS-c represents a potential target for drug development aimed at modulating its signaling pathways to treat metabolic disorders and neurodegenerative diseases.

 Source: PubMed · Pathol Res Pract · published 2026-02-01.

## Sources

- PubMed · Pathol Res Pract: https://pubmed.ncbi.nlm.nih.gov/41468641/